Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

被引:62
|
作者
Overbeek, Maria J. [1 ]
Mouchaers, Koen T. B. [1 ]
Niessen, Hans M. [2 ,3 ]
Hadi, Awal M. [1 ]
Kupreishvili, Koba [2 ]
Boonstra, Anco [1 ]
Voskuyl, Alexandre E. [4 ]
Belien, Jeroen A. M. [2 ]
Smit, Egbert F. [1 ]
Dijkmans, Ben C. [4 ]
Vonk-Noordegraaf, Anton [1 ]
Grunberg, Katrien [2 ]
机构
[1] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pulm Dis, Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Cardiac Surg, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1155/2010/604615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a disturbed function of the right ventricle (RV) when compared to idiopathic PAH (IPAH). Systemic sclerosis may also affect the heart. We hypothesize that RV differences may occur at the level of interstitial inflammation and-fibrosis and compared inflammatory cell infiltrate and fibrosis between the RV of SScPAH, IPAH, and healthy controls. Methods. Paraffin-embedded tissue samples of RV and left ventricle (LV) from SScPAH (n = 5) and IPAH (n = 9) patients and controls (n = 4) were picrosirius red stained for detection of interstitial fibrosis, which was quantified semiautomatically. Neutrophilic granulocytes (MPO), macrophages (CD68), and lymphocytes (CD45) were immunohistochemically stained and only interstitial leukocytes were counted. Presence of epi-or endocardial inflammation, and of perivascular or intimal fibrosis of coronary arteries was assessed semiquantitatively (0-3: absent to extensive). Results. RV's of SScPAH showed significantly more inflammatory cells than of IPAH (cells/mm(2), mean +/- sd MPO 11 +/- 3 versus 6 +/- 1; CD68 11 +/- 3 versus 6 +/- 1; CD45 11 +/- 1 versus 5 +/- 1, P < .05) and than of controls. RV interstitial fibrosis was similar in SScPAH and IPAH (4 +/- 1 versus 5 +/- 1%, P = .9), and did not differ from controls (5 +/- 1%, P = .8). In 4 SScPAH and 5 IPAH RV's foci of replacement fibrosis were found. No differences were found on epi-or endocardial inflammation or on perivascular or intimal fibrosis of coronary arteries. Conclusion. SScPAH RVs display denser inflammatory infiltrates than IPAH, while they do not differ with respect to interstitial fibrosis. Whether increased inflammatory status is a contributor to altered RV function in SScPAH warrants further research.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Sex Disparities In Survival Of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension And Idiopathic Pulmonary Arterial Hypertension Patients
    Pasarikovski, C.
    Granton, J. T.
    Lee, P.
    Roos, A. M.
    Kron, A.
    Chau, C.
    Johnson, S. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] CHARACTERISTICS OF QUANTITATIVE CT ANALYSIS AND PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Jesudasen, Sirus
    Patel, Badar
    D'Silva, Kristin
    Nardelli, Pietro
    Estepar, Ruben San Jose
    Washko, George
    Estepar, Raul San Jose
    Rahaghi, Farbod
    Montesi, Sydney
    CHEST, 2021, 160 (04) : 2145A - 2146A
  • [33] Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
    Friedman, Samuel H.
    Harley, Russell A.
    Williams, Jacob
    Forcucci, Jessica A.
    Ramakrishnan, Viswanathan
    Strange, Charlie
    Silver, Richard M.
    Feghali-Bostwick, Carol
    Argula, Rahul G.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2024,
  • [34] Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Lai, Jinzhi
    Zhao, Jiuliang
    Li, Kaiwen
    Qin, Xiaohan
    Wang, Hui
    Tian, Zhuang
    Wang, Qian
    Li, Mengtao
    Guo, Xiaoxiao
    Liu, Yongtai
    Zeng, Xiaofeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [35] An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature
    Sneha M. Sundaram
    Lorinda Chung
    Current Rheumatology Reports, 2018, 20
  • [36] Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
    Christopher R. Pasarikovski
    John T. Granton
    Adrienne M. Roos
    Saghar Sadeghi
    Amie T. Kron
    John Thenganatt
    Jakov Moric
    Cathy Chau
    Sindhu R. Johnson
    Arthritis Research & Therapy, 18
  • [37] Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
    Pasarikovski, Christopher R.
    Granton, John T.
    Roos, Adrienne M.
    Sadeghi, Saghar
    Kron, Amie T.
    Thenganatt, John
    Moric, Jakov
    Chau, Cathy
    Johnson, Sindhu R.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [38] An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature
    Sundaram, Sneha M.
    Chung, Lorinda
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (02)
  • [39] Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
    Launay, David
    Sitbon, Olivier
    Hachulla, Eric
    Mouthon, Luc
    Gressin, Virginie
    Rottat, Laurence
    Clerson, Pierre
    Cordier, Jean-Francois
    Simonneau, Gerald
    Humbert, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1940 - 1946
  • [40] Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Xanthouli, Panagiota
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (03) : 238 - 240